Results 81 to 90 of about 29,875 (183)

Correction: The 2024 resurgence of <i>Bordetella pertussis</i> in Brazil and a decade-long epidemiological overview. [PDF]

Front Public Health
Sansone NMS, Boschiero MN, Marson FAL.
europepmc   +1 more source

Correction: Acylation of Lysine 983 Is Sufficient for Toxin Activity of Bordetella pertussis Adenylate Cyclase. [PDF]

J Biol Chem
Basar T, Havlíček V, Bezoušková S, Hackett M, Ŝebo P.   +4 more
europepmc   +1 more source

Clinical characteristics and predictors of Mycoplasma pneumoniae pneumonia coinfection with Bordetella pertussis in children. [PDF]

Medicine (Baltimore)
Lai C, Peng S, Wu X.
europepmc   +1 more source

Bordetella pertussis [PDF]

, 2020
openaire   +2 more sources

<i>Bordetella pertussis</i> Infection: From Immune Pathogenesis to Next-Generation Vaccines. [PDF]

Vaccines (Basel)
Georgakopoulou VE, Pitiriga VC.
europepmc   +1 more source

Comment on "sharp rise in high-virulence <i>Bordetella pertussis</i> with macrolides resistance in Northern China". [PDF]

Emerg Microbes Infect
Li Z, Li Z, Ma X.
europepmc   +1 more source

Pangenomics-Driven Reverse Vaccinology for the Discovery of New Vaccine Candidates Against <i>Bordetella pertussis</i>. [PDF]

Bioinform Biol Insights
Abdelouahab M, Idrissa D.
europepmc   +1 more source

Evolution of Bordetella pertussis

Pediatric Infectious Disease Journal, 2016
openaire   +3 more sources

Antimicrobial resistance in <i>Bordetella pertussis</i>: A systematic review and meta-analysis. [PDF]

Epidemiol Infect
Ma K, Sun W, Pan G, Xu Y, Shi Y, Chen Y.
europepmc   +1 more source

Released palmitic acid-mediated TLR4/NF-κB activation enhances the virulence of Bordetella pertussis MT28 lineage. [PDF]

Nat Commun
Li S, Chen M, Feng X, Gao Y, Hong X, Nurxat N, Chen T, Xiang G, Yang Z, Jian Y, Wei Q, Shi B, Ma X, Lu Y, Shen Z, Wei M, He L, Li M.   +17 more
europepmc   +1 more source